CLINICAL_TRIALS
trial_result
· 2012-09-20
Clinical Trial Update: Evaluating The Safety Of Exemestane Following 2-3 Years Of Adjuvant Tamoxifen Therapy In Postmenopausal Early Breast Cancer Patients
Summary
A terminated clinical trial evaluating the safety of exemestane after 2-3 years of adjuvant tamoxifen in postmenopausal patients with early breast cancer; resul…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Early Breast Cancer | Status: TERMINATED | Results posted: 2012-09-20